Maternal DNA Methylation and Congenital Heart Defects
Author Information
Author(s): Chowdhury Shimul, Erickson Stephen W., MacLeod Stewart L., Cleves Mario A., Hu Ping, Karim Mohammad A., Hobbs Charlotte A.
Primary Institution: University of Arkansas for Medical Sciences
Hypothesis
Are alterations in maternal gene-specific DNA methylation associated with congenital heart defects (CHDs)?
Conclusion
The study suggests that alterations in maternal DNA methylation may be associated with congenital heart defects.
Supporting Evidence
- 180 mothers with CHD-affected pregnancies and 187 mothers with unaffected pregnancies were included in the study.
- 425 differentially methylated CpG sites were identified between cases and controls.
- Most differentially methylated sites were hypermethylated in cases and located within CpG islands.
- Gene Set Enrichment Analysis revealed significant biological processes related to fetal development.
Takeaway
This study looked at how changes in a mother's DNA might affect her baby's heart development. They found some links between these changes and heart problems in babies.
Methodology
A population-based case-control study was conducted to assess maternal gene-specific DNA methylation using the Illumina Infinium Human Methylation27 BeadChip.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the reliance on self-reported lifestyle factors.
Limitations
The study did not measure DNA methylation changes during gestation and lacked infant methylation data to correlate with maternal patterns.
Participant Demographics
The majority of participants were Caucasian women, with ages primarily under 30.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website